Skip to main content

Ujjal Didar Singh Sekhon

FY2025 NIH rank #17,487
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14355988Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$944.7K
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#17,487
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ujjal Didar Singh Sekhon. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Ujjal Didar Singh Sekhon as a PI. Multi-PI records show the full award amount for context.

  • 1R44HL180258-01R44
    A Novel Platelet-Inspired Nanotechnology to Restore Hemostasis in Patients on Antiplatelet Agents
    $944.7K
    award amount

Award organization

Organizations that administered FY2025 awards listing Ujjal Didar Singh Sekhon as a PI.

FY2025 award administered by Haima Therapeutics, Llc (OH).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Haima Therapeutics, Llc
  2. 2025
    $500K Cumulative Funding
  3. 2026
    $1M Cumulative Funding